Abstract:Protein-protein interaction s (PPIs) monitoring is critical to reveal cellular fundamental mechanism and facilitate drugs discovery. Nevertheless, the facial and robust protein 53 (p53)-murine double minute2 (MDM2) interaction detection methods remain challenging. Herein, we developed a PPIs detection platform based on CRISPR-Cas12a sensing system for the first time for p53-MDM2 interaction monitoring and inhibitors potency evaluation, designated Cas-PPIor ( Cas 12a-mediated PPI s detect or ). Inspired by the conformational-dependent consensus DNA binding ability of p53, a double stranded DNA (dsDNA) probe was designed elaborately through incorporating Cas12a activation domain into the specific p53 DNA-binding sequence. Thus, the PPI event can then be transduced into the collateral cleavage activity of Cas12a. As both the Cas12a/single-guide RNA (sgRNA) complex and p53 can bind to the same dsDNA probe in a competitive manner, the activated Cas12a mediated fluorescent readout scaled negatively with the p53 binding. Accordingly, we monitored the p53-MDM2 interaction process as well as its inhibition by a small-molecule antagonist. Based on the sequence specific binding of wild p53, our designed Cas-PPIor achieved high accuracy for differentiation of wild-type p53 cells from p53 mutation or deletion cells. Through discriminating p53 levels from cellular matrix treated with enantiomers of Nutlin-3, the assay also demonstrated reliable capability to evaluate drugs antiproliferative potency. By integrating the DNA binding ability of proteins with intrinsic flexible programmability and outstanding sensitivity of Cas12a, the proposed Cas-PPIor methodology hold great potential to enable accurate and facial PPIs monitoring and inhibitors potency evaluations.

The Dihydrofolate Reductase Protein-Fragment Complementation Assay: A Survival-Selection Assay for Large-Scale Analysis of Protein-Protein Interactions

Protein-fragment complementation assays for large-scale analysis, functional dissection and dynamic studies of protein-protein interactions in living cells

Detection of protein-protein interactions using a simple survival protein-fragment complementation assay based on the enzyme dihydrofolate reductase

A Semiquantitative Protein-Fragment Complementation Assay to Study Protein-Protein Interactions of the Polymerase Complex in Cellula

An improved and highly selective fluorescence assay for measuring phosphatidylserine decarboxylase activity

An Adaptable Luminescence Resonance Energy Transfer Assay for Measuring and Screening Protein-Protein Interactions and their Inhibition.

Immobilized Fusion Protein Affinity Chromatography Combined with HPLC–ESI-Q-TOF-MS/MS for Rapid Screening of PPARγ Ligands from Natural Products

Three decades of protein-fragment complementation

Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF BRD/Tat-AcK50 association.

Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase

The fluorescent two-hybrid assay to screen for protein-protein interaction inhibitors in live cells: targeting the interaction of p53 with Mdm2 and Mdm4.

Selection and Evolution of Disulfide-Rich Peptides Via Cellular Protein Quality Control

Protein-Protein Interaction Monitoring and Inhibitors Potency Evaluation Based on Crispr-Cas12a Sensing Platform

A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors

Rapid Quantification of Cellular Deoxyribonucleoside Triphosphates by Rolling Circle Amplification and FRET

Accurate and sensitive interactome profiling using a quantitative protein-fragment complementation assay

High-Fidelity and Simultaneous Sensing of Endogenous Mutant and Wild p53 Proteins for Precise Cancer Diagnosis and Drug Screening

Deep quantification of substrate turnover defines protease subsite cooperativity

Evaluation of DNA Methyltransferase Activity and Inhibition Via Isothermal Enzyme-Free Concatenated Hybridization Chain Reaction

Assay for expression of methotrexate-resistant dihydrofolate reductase activity in the presence of drug-sensitive enzyme

P53-MDM2 interaction monitoring and inhibitors potency evaluation based on CRISPR-Cas12a sensing platform